Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

469

WORD

268

HTML

5820

Figures (1-3)

201

Sum=6758

Publishing Process of This Article

Item

Count

Browse

883

Download

515

Sum=1398

Jun 26, 2014 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Cardiol. Jun 26, 2014; 6(6): 507-513
Published online Jun 26, 2014. doi: 10.4330/wjc.v6.i6.507

Full Size Figure Download Figure

Figure 3 Dose and time-dependency of the development of peripheral oedema. Adapted from the second meta-analysis[7].

Citation: Elliott HL, Meredith PA. Thrapeutic equivalence in the treatment of hypertension: Can lercanidipine and nifedipine GITS be considered to be interchangeable? World J Cardiol 2014; 6(6): 507-513
URL: https://www.wjgnet.com/1949-8462/full/v6/i6/507.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i6.507